logo-loader
viewCircassia Group PLC

Circassia Group Plc - Annual report and notice of AGM

RNS Number : 2413Q
Circassia Group Plc
17 June 2020
 

 

Circassia Group plc

 

Annual Report and Accounts for the year ended 31 December 2019 and Notice of 2020 Annual General Meeting

 

 

17 June 2020

 

Circassia Group plc announces that its Annual Report and Accounts for the year ended 31 December 2019 and Notice of 2020 Annual General Meeting have been published on the Company's website: www.circassia.com.  Additionally, these documents have been posted, or otherwise made available, to shareholders.

The Annual General Meeting will be held at 10.00 a.m. on Thursday 23 July 2020 at the Company's offices: Northbrook House, Robert Robinson Avenue, Oxford, OX4 4GA.

 

-Ends-

 

Contacts

Circassia

Ian Johnson, Executive Chairman                                                                c/o Peel Hunt

Michael Roller, Chief Financial Officer

 

Peel Hunt (Nominated Adviser and Joint Broker)

James Steel / Oliver Jackson                                                                        Tel: +44 (0) 20 7418 8900

 

finnCap (Joint Broker)

Geoff Nash / Alice Lane                                                                                Tel: +44 (0) 20 7220 0500

 

Numis Securities (Joint Broker)

James Black / Duncan Monteith                                                                    Tel: +44 (0) 20 7260 1000

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ACSFRMLTMTTBMBM

Quick facts: Circassia Group PLC

Price: 31.6

Market: LSE
Market Cap: £119.13 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Circassia Pharmaceuticals' commercial development...

Circassia Pharmaceuticals PLC's (LON:CIR) CEO Steve Harris tells Proactive London's Andrew Scott they saw strong growth in the first half of the year alongside a reduction in costs and cash outflows. Revenues for the six months ended June 30 were up 40% year-on-year at £27.9mln, with the...

on 26/9/19